Researchers are ushering in a new era of vaccine design that promises to be faster, more precise, and capable of tackling humanity’s most stubborn diseases.

Fianna Fáil’s four MEPs will not be supporting a motion of no-confidence in European Commission president Ursula von der Leyen this week, which has been tabled by far-right parties.

Supporters of a motion of censure against Commission President Ursula von der Leyen hope it will put enough political pressure on her leadership to force a resignation – mirroring the 1999 downfall of ...

EU chief Ursula von der Leyen faces a confidence vote Thursday that has little chance of succeeding but has exposed frictions ...

The motion, brought forward by far-right lawmakers, was overwhelmingly defeated. A total of 360 MEPs voted against it, while 175 supported it and 18 abstained. Of the 720 members of the Parliament, ...

The European Commission president was forced to walk away from $165 billion in economic competitiveness reforms and defense spending pivots, exposing Europe's struggle to match U.S. and Chinese ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

Pfizer’s announcement about the effectiveness of its Covid-19 vaccine came nearly a week after Election Day, but Pfizer CEO Albert Bourla has said the timing had nothing to do with politics.

The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.

A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...